Drugmakers quickly voiced their opposition to the move, but public health advocates were elated. Waiving patent rights, the thinking goes, will give poorer countries the ability to procure low-cost generic versions of COVID-19 vaccines, even if they are produced in another country, and help them to more effectively fight a public health crisis. The European Parliament now supports the idea as well.
The United States, Europe and other wealthy parts of the world have already vaccinated large parts of their populations, yet vaccine rates in poor countries are lagging badly. That’s why the surprise announcement last spring that the […]
Click here to visit source. economictimes.indiatimes.com
See also U.S. beats Denmark for 5th straight win at ice hockey worlds
Powered by Inline Related Posts